[go: up one dir, main page]

ECSP18039758A - TRIESPECIFIC AND / OR TRIVALENT BINDING PROTEINS FOR THE PREVENTION OR TREATMENT OF HIV INFECTION - Google Patents

TRIESPECIFIC AND / OR TRIVALENT BINDING PROTEINS FOR THE PREVENTION OR TREATMENT OF HIV INFECTION

Info

Publication number
ECSP18039758A
ECSP18039758A ECIEPI201839758A ECPI201839758A ECSP18039758A EC SP18039758 A ECSP18039758 A EC SP18039758A EC IEPI201839758 A ECIEPI201839758 A EC IEPI201839758A EC PI201839758 A ECPI201839758 A EC PI201839758A EC SP18039758 A ECSP18039758 A EC SP18039758A
Authority
EC
Ecuador
Prior art keywords
binding proteins
trivalent
prevention
treatment
triespecific
Prior art date
Application number
ECIEPI201839758A
Other languages
Spanish (es)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of ECSP18039758A publication Critical patent/ECSP18039758A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

En la presente memoria se proporcionan que comprenden proteínas de unión triespecíficas y/o trivalentes que comprenden cuatro cadenas polipeptídicas que forman tres sitios de unión a antígeno que se unen específicamente a una o más proteínas diana del VIH o uno o más receptores de células T, en donde un primer par de polipéptidos que forman la proteína de unión posee dominios variables duales que tienen una orientación cruzada y en donde un segundo par de polipéptidos que forman la proteína de unión posee un solo dominio variable. También se proporcionan en la presente memoria métodos para preparar proteínas de unión triespecíficas y/o trivalentes y usos de tales proteínas de unión para el tratamiento y/o la prevención de VIH/SIDA.Provided herein are that they comprise trivalent and / or trivalent binding proteins comprising four polypeptide chains that form three antigen-binding sites that specifically bind to one or more HIV target proteins or one or more T cell receptors, wherein a first pair of polypeptides that make up the binding protein possesses dual variable domains that are cross-oriented and wherein a second pair of polypeptides that make up the binding protein possesses a single variable domain. Also provided herein are methods for preparing trivalent and / or trivalent binding proteins and uses of such binding proteins for the treatment and / or prevention of HIV / AIDS.

ECIEPI201839758A 2015-10-25 2018-05-24 TRIESPECIFIC AND / OR TRIVALENT BINDING PROTEINS FOR THE PREVENTION OR TREATMENT OF HIV INFECTION ECSP18039758A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201562246113P 2015-10-25 2015-10-25
EP16305211 2016-02-24
US201662322029P 2016-04-13 2016-04-13
US201662331169P 2016-05-03 2016-05-03

Publications (1)

Publication Number Publication Date
ECSP18039758A true ECSP18039758A (en) 2018-10-31

Family

ID=69671420

Family Applications (1)

Application Number Title Priority Date Filing Date
ECIEPI201839758A ECSP18039758A (en) 2015-10-25 2018-05-24 TRIESPECIFIC AND / OR TRIVALENT BINDING PROTEINS FOR THE PREVENTION OR TREATMENT OF HIV INFECTION

Country Status (5)

Country Link
DK (1) DK3365366T3 (en)
EC (1) ECSP18039758A (en)
LT (1) LT3365366T (en)
SG (1) SG10202003467RA (en)
TN (1) TN2018000137A1 (en)

Also Published As

Publication number Publication date
SG10202003467RA (en) 2020-05-28
TN2018000137A1 (en) 2019-10-04
DK3365366T3 (en) 2021-10-18
LT3365366T (en) 2021-11-25

Similar Documents

Publication Publication Date Title
CO2018005337A2 (en) Trispecific and / or trivalent binding proteins for the prevention or treatment of HIV infection
CO2018012107A2 (en) Trispecific and / or trivalent binding proteins
CO2018009995A2 (en) Binding proteins and methods of use thereof
MX377753B (en) ANTI-LAG3 ANTIBODIES AND ANTIGEN-BINDING FRAGMENTS.
PE20171180A1 (en) ANTI-PD-1 ANTIBODIES AND THEIR METHODS OF USE
EA201692394A1 (en) ANTIBODIES AND ANTIGENS-BINDING FRAGMENTS, WHICH SPECIFICALLY CONNECT WITH THE PROUCH OF TAU ASSOCIATED WITH MICROTUBULES
WO2016106159A8 (en) Anti-pd-1 antibodies
EA201891732A1 (en) BISPECIFIC BINDING PROTEINS FOR PD-L1 AND KDR
MX2017005977A (en) Bispecific antibodies and methods of use in ophthalmology.
CO2021014918A2 (en) Trispecific binding proteins, methods and uses thereof
CU20170012A7 (en) ANTIBODIES ANTI PROTEIN SIMILAR TO ANGIOPOYETINA 4
CO2021014988A2 (en) Trispecific and/or trivalent binding proteins using the crossover dual domain variable (codv) format for the treatment of hiv infection
AR101671A1 (en) ANTIBODIES ANTI PROTEIN SIMILAR TO ANGIOPOYETINA-4 (ANGPTL4) AND METHODS OF USE
EA201892096A1 (en) NEUTRALIZING MONOCLONAL ANTIBODIES TO IL-25 AND THEIR APPLICATION
MX2023004804A (en) Trispecific and/or trivalent binding proteins.
EA201892085A1 (en) NEW PROTEINS OBTAINED FROM ALPHA-1-MICROGLOBULIN AND THEIR APPLICATION
ECSP18039758A (en) TRIESPECIFIC AND / OR TRIVALENT BINDING PROTEINS FOR THE PREVENTION OR TREATMENT OF HIV INFECTION
AR118602A1 (en) TRIESPECIFIC AND / OR TRIVALENT BINDING PROTEINS FOR THE TREATMENT OF HIV INFECTION
ECSP18084491A (en) TRIESPECIFIC AND / OR TRIVALENT BINDING PROTEINS
EA202191078A2 (en) TRISSPECIFIC AND / OR TRIVALENT BINDING PROTEINS FOR PREVENTION OR TREATMENT OF HIV INFECTION
AR108210A1 (en) THREE-SPECIFIC AND / OR TRIVAL UNION PROTEINS
HK1243092A1 (en) Fn14-binding proteins and uses thereof